What does APOTEEK GINDERBUITEN do?

APOTEEK GINDERBUITEN is a pharmacy in Mol. Private Limited, started on 24 January 1985, 1 establishment.

What is the address of APOTEEK GINDERBUITEN?

The registered office of APOTEEK GINDERBUITEN is located at Ginderbuiten 119, 2400 Mol.

Is APOTEEK GINDERBUITEN still active?

Yes. According to the CBE (29 October 2026) APOTEEK GINDERBUITEN is active, legal situation “Normale toestand”, started on 24 January 1985.

Is APOTEEK GINDERBUITEN registered on Peppol?

Yes, APOTEEK GINDERBUITEN is registered on the Peppol network with ID 0208:0426798515.

What is the enterprise number of APOTEEK GINDERBUITEN?

The enterprise number of APOTEEK GINDERBUITEN is BE0426798515.

When was APOTEEK GINDERBUITEN founded?

APOTEEK GINDERBUITEN was founded on 24 January 1985.

Who are the directors of APOTEEK GINDERBUITEN?

According to the 2025 annual accounts, the directors of APOTEEK GINDERBUITEN are: TOMKAT BV.

Is APOTEEK GINDERBUITEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 January 1985; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTEEK GINDERBUITEN make in 2025?

APOTEEK GINDERBUITEN posted a profit after taxes of € 35,956 in financial year 2025.

What is the revenue of APOTEEK GINDERBUITEN?

As a small company, APOTEEK GINDERBUITEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 304,987.

How much does an employee at APOTEEK GINDERBUITEN earn?

The average wage cost per full-time employee at APOTEEK GINDERBUITEN was € 88,000 in 2025: staff costs of € 228,867 for 2.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTEEK GINDERBUITEN have?

According to the 2025 annual accounts, APOTEEK GINDERBUITEN has 2.6 full-time equivalents (FTE).

APOTEEK GINDERBUITEN (Private Limited) - Mol

Dossier APOTEEK GINDERBUITEN, printed on 29 October 2026 from databakkes.be/en/0426798515/apoteek-ginderbuiten. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2022.

Financials

Financial year 2025

APOTEEK GINDERBUITEN from Mol, company number BE0426798515, closed financial year 2025 with a result of € 35,956 after tax. For that financial year APOTEEK GINDERBUITEN recorded a gross margin of € 304,987 and equity of € 111,052. Compared with financial year 2024, the result moved from € 186,388 to € 35,956. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Growing

€ 111,052

▲ 48% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 35,956

▼ 81% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 115,501

▼ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 92,452.

People and assets in 2025

Full-time equivalents

2.6

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 228,867

▲ 14% vs 2024

€ 88,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,852

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 224,219

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 247,624

▲ 157% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 41,752

▼ 21% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 501,095 Gross margin 2022: € 501,095 First fiscal year in the series	€ 466,559 Gross margin 2023: € 466,559 ▼ 7% vs 2022 (€ 501,095) Unfavourable step	€ 486,607 Gross margin 2024: € 486,607 ▲ 4% vs 2023 (€ 466,559) Favourable step	€ 304,987 Gross margin 2025: € 304,987 ▼ 37% vs 2024 (€ 486,607) Unfavourable step	▼ 37%
Profit after taxes	€ 217,387 Profit after taxes 2022: € 217,387 First fiscal year in the series	€ 183,281 Profit after taxes 2023: € 183,281 ▼ 16% vs 2022 (€ 217,387) Unfavourable step	€ 186,388 Profit after taxes 2024: € 186,388 ▲ 2% vs 2023 (€ 183,281) Favourable step	€ 35,956 Profit after taxes 2025: € 35,956 ▼ 81% vs 2024 (€ 186,388) Unfavourable step	▼ 81%
Equity	€ 70,426 Equity 2022: € 70,426 First fiscal year in the series	€ 73,708 Equity 2023: € 73,708 ▲ 5% vs 2022 (€ 70,426) Favourable step	€ 75,096 Equity 2024: € 75,096 ▲ 2% vs 2023 (€ 73,708) Favourable step	€ 111,052 Equity 2025: € 111,052 ▲ 48% vs 2024 (€ 75,096) Favourable step	▲ 48%
Total debts	€ 589,463 Total debts 2022: € 589,463 First fiscal year in the series	€ 554,383 Total debts 2023: € 554,383 ▼ 6% vs 2022 (€ 589,463) Favourable step	€ 590,670 Total debts 2024: € 590,670 ▲ 7% vs 2023 (€ 554,383) Unfavourable step	€ 581,145 Total debts 2025: € 581,145 ▼ 2% vs 2024 (€ 590,670) Favourable step	▼ 2%
Cash	€ 190,714 Cash 2022: € 190,714 First fiscal year in the series	€ 153,112 Cash 2023: € 153,112 ▼ 20% vs 2022 (€ 190,714) Unfavourable step	€ 159,206 Cash 2024: € 159,206 ▲ 4% vs 2023 (€ 153,112) Favourable step	€ 115,501 Cash 2025: € 115,501 ▼ 27% vs 2024 (€ 159,206) Unfavourable step	▼ 27%
Retained profit	€ 51,826 Retained profit 2022: € 51,826 First fiscal year in the series	€ 55,108 Retained profit 2023: € 55,108 ▲ 6% vs 2022 (€ 51,826) Favourable step	€ 56,496 Retained profit 2024: € 56,496 ▲ 3% vs 2023 (€ 55,108) Favourable step	€ 92,452 Retained profit 2025: € 92,452 ▲ 64% vs 2024 (€ 56,496) Favourable step	▲ 64%
Dividend	€ 210,000 Dividend 2022: € 210,000 First fiscal year in the series	€ 180,000 Dividend 2023: € 180,000 ▼ 14% vs 2022 (€ 210,000) Unchanged	€ 185,000 Dividend 2024: € 185,000 ▲ 3% vs 2023 (€ 180,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 185,000) Unchanged	▼ 100%
Bank debt	€ 233,732 Bank debt 2022: € 233,732 First fiscal year in the series	€ 224,167 Bank debt 2023: € 224,167 ▼ 4% vs 2022 (€ 233,732) Favourable step	€ 224,167 Bank debt 2024: € 224,167 Unchanged (€ 224,167) Unchanged	€ 224,219 Bank debt 2025: € 224,219 Unchanged (€ 224,167) Unfavourable step
Balance sheet total	€ 659,889 Balance sheet total 2022: € 659,889 First fiscal year in the series	€ 628,091 Balance sheet total 2023: € 628,091 ▼ 5% vs 2022 (€ 659,889) Unchanged	€ 665,766 Balance sheet total 2024: € 665,766 ▲ 6% vs 2023 (€ 628,091) Unchanged	€ 692,197 Balance sheet total 2025: € 692,197 ▲ 4% vs 2024 (€ 665,766) Unchanged	▲ 4%
Employees (FTE)	2.5 Employees (FTE) 2022: 2.5 First fiscal year in the series	2.6 Employees (FTE) 2023: 2.6 ▲ 0.1 vs 2022 (2.5) Unchanged	2.6 Employees (FTE) 2024: 2.6 Unchanged (2.6) Unchanged	2.6 Employees (FTE) 2025: 2.6 Unchanged (2.6) Unchanged

Key figures of APOTEEK GINDERBUITEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTEEK GINDERBUITEN?

What happened at APOTEEK GINDERBUITEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: profit of € 35,956 (▼ 81% vs 2024). Source: NBB ↗
2020 TOMKAT BV became a director. NBB
Feb 19, 1985 New establishment in Mol. KBO
Jan 24, 1985 Start of the company according to the CBE. KBO

In short

From € 217,387 profit in 2022 to € 35,956 profit in 2025.

Paid € 220,627 in corporate taxes since 2022.

Best year ever: 2022, with € 217,387 profit.

On average € 117,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

TOMKAT 0%

The stake of TOMKAT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTEEK GINDERBUITEN

Behind APOTEEK GINDERBUITEN is TOMKAT BV. The shares are held by TOMKAT (0%).

Directors

According to the 2025 annual accounts

TOMKAT BV

Director · represented by CROUX KATHLEEN

Also active at: Stebofisc

since 2020

Shareholders

TOMKAT

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Ginderbuiten 119

2400 Mol

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.798.515

VAT number

BE 0426.798.515

Registered office

Ginderbuiten 119, 2400 Mol

Names & denominations

APOTEEK GINDERBUITEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 January 1985

Peppol

Active · Active since 4 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTEEK GINDERBUITEN

Warning lights

Financials

What happened to APOTEEK GINDERBUITEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions